A Phase I/II Study of LY900003, an Antisense Inhibitor of Protein Kinase C-α, in Combination with Cisplatin and Gemcitabine in Patients with Advanced Non–Small Cell Lung Cancer
VILLALONA-CALERO, Miguel A, RITCH, Paul, MODIANO, Manuel, VALDIVIESO, Manuel, GEARY, Richard, OLIVER, Jennifer W, HOLMLUND, Jon, FIGUEROA, Jose A, OTTERSON, Gregory A, BELT, Robert, DOW, Edward, GEORGE, Sebastian, LEONARDO, James, MCCACHREN, Spence, MILLER, G. Lance
Published in Clinical cancer research (15.09.2004)
Published in Clinical cancer research (15.09.2004)
Get full text
Journal Article